Rat optic nerve (ON) transection leads to mainly apoptotic cell death of about 85% of the retinal ganglion cell (RGC) population within 14 days after lesion. In the present study, we tested the effect of adenovirally delivered CNTF (Ad-CNTF) on survival and regeneration of axotomized adult RGCs in vivo. Single intravitreal Ad-CNTF injection led to stable CNTF mRNA and protein expression for at least 18 days and significantly enhanced RGC survival by 155% when compared to control animals 14 days after ON transection. ON stump application of Ad-CNTF also resulted in an increased number of surviving RGCs. Ad-CNTF injection led to better preservation of intraretinal RGC axons but did not support regeneration of axotomized RGCs into a peripheral nerve graft. Thus, adenovirus-mediated neurotrophic factor supply is a suitable approach for reducing axotomy-induced RGC death in vivo and may constitute a relevant strategy for clinical treatment of traumatic brain injury.
INTRODUCTION
Retrograde neuronal degeneration and secondary neuronal death are common cell responses following axotomy in the adult mammalian CNS (Bähr and Bonhoeffer, 1994; Garcia Valenzuela et al., 1994) . Transection of the rat optic nerve (ON) consistently leads to neuronal death of about 85% of the entire retinal ganglion cell (RGC) population within 14 days after injury (Villegas Perez et al., 1993; Klö cker et al., 1997) . Secondary death of RGCs following ON axotomy has been characterized as mainly apoptotic cell death (Berkelaar et al., 1994; Garcia-Valenzuela et al., 1994; Isenmann et al., 1997) . Among other neurotrophic factors such as brain-derived neurotrophic factor (BDNF), neurotrophin 4 (NT-4) and glial cell line-derived neurotrophic factor (GDNF), ciliary neurotrophic factor (CNTF) has been shown to have survival-promoting effects on RCGs after rat ON transection. Repeated intraocular injections of these neurotrophic factors at least temporarily rescued RGCs from axotomy-induced death (Mey and Thanos, 1993; Peinado-Ramon et al., 1996; Klö cker et al., 1997 Klö cker et al., , 1998 . RGCs have previously been identified as a retinal expression site of CNTF receptor ␣ (CNTFR␣; Kirsch et al., 1997) , which is crucial for the formation of the CNTFR complex, the prerequisite for CNTF-induced intracellular signaling (Stahl and Yancopoulus, 1994) . This indicates that CNTF might exert its neuroprotective effect via the CNTFR complex by initiating an intracellular signaling cascade, which might delay apoptotic death of axotomized RGCs.
Despite of promising results regarding the neuroprotective capacity of neurotrophic factors in different injury models, repeated injections of these molecules into the CNS remain an unsolved problem and have proven a major obstacle for designing feasible treatment strategies in human patients. The application of adenoviral vectors for gene delivery offers a new tool to overcome the necessity of multiple and potentially
